Stone House Investment Management’s Edwards Lifesciences EW Stock Holding History

Stone House Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-199	Closed	-$15.6K	–	735
2025 Q2	$15.6K	Hold	199	–	–	﹤0.01%	227
2025 Q1	$14.4K	Buy	+199	New	+$14.2K	﹤0.01%	228
2024 Q4	–	Sell	-201	Closed	-$13.3K	–	159
2024 Q3	$13.3K	Hold	201	–	–	﹤0.01%	206
2024 Q2	$18.6K	Hold	201	–	–	﹤0.01%	191
2024 Q1	$19.2K	Hold	201	–	–	﹤0.01%	194
2023 Q4	$15.3K	Hold	201	–	–	0.01%	138
2023 Q3	$13.9K	Hold	201	–	–	﹤0.01%	139
2023 Q2	$19K	Hold	201	–	–	0.01%	123
2023 Q1	$16.6K	Buy	+201	New	+$15.8K	0.01%	134

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return

Stone House Investment Management's EW Position: Q3 2025 in Review

Stone House Investment Management sold out of Edwards Lifesciences (EW) in Q3 2025, closing a stake of 199 shares — an estimated $15.6K sold.

Stone House Investment Management first reported a position in EW in Q1 2023 and held it in 9 quarters. The position peaked at $19.2K in Q1 2024. 1,255 funds tracked by Wall St. Rank hold EW as of Q3 2025.

Stone House Investment Management reported no remaining Edwards Lifesciences position as of Q3 2025 after selling out during the quarter.
Stone House Investment Management sold 199 Edwards Lifesciences shares in Q3 2025, an estimated $15.6K.
Stone House Investment Management first reported a position in Edwards Lifesciences in Q1 2023 and held it in 9 quarters.
Stone House Investment Management's Edwards Lifesciences position peaked at $19.2K in Q1 2024.
1,255 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2025.

Based on Stone House Investment Management's 13F filing for Q3 2025, filed 27 Oct 2025.